BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

292 hedge funds and large institutions have $1.77B invested in BioCryst Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 112 increasing their positions, 84 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
292
Holders Change
+20
Holders Change %
+7.35%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
52
Increased
112
Reduced
84
Closed
30
Calls
$12.7M
Puts
$6.52M
Net Calls
+$6.18M
Net Calls Change
+$1.41M

Top Buyers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$36.6M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$32.3M
3
UBS Group
UBS Group
Switzerland
+$28.8M
4
Morgan Stanley
Morgan Stanley
New York
+$27.2M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$25.1M

Top Sellers

1
ACA
Avoro Capital Advisors
New York
-$37.6M
2
CP
Caligan Partners
New York
-$22.1M
3
Millennium Management
Millennium Management
New York
-$17.1M
4
Ameriprise
Ameriprise
Minnesota
-$14.7M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$13.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
JAM
26
Jupiter Asset Management
United Kingdom
$18.6M -$636K -71,003 -3%
RHJA
27
Rice Hall James & Associates
California
$18.5M +$293K +32,712 +2%
Charles Schwab
28
Charles Schwab
California
$17.7M +$429K +47,837 +2%
Northern Trust
29
Northern Trust
Illinois
$17.1M -$372K -41,529 -2%
Millennium Management
30
Millennium Management
New York
$17.1M -$17.1M -1,906,207 -50%
Stifel Financial
31
Stifel Financial
Missouri
$16.3M -$123K -13,691 -0.7%
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
$14.2M +$4.65M +518,623 +49%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$13.1M +$11.9M +1,331,230 +1,060%
JF
34
Jump Financial
Illinois
$12.1M +$10.7M +1,198,263 +805%
Connor, Clark & Lunn Investment Management (CC&L)
35
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$11.3M +$1.93M +215,267 +21%
HRCM
36
Hood River Capital Management
Florida
$11.1M +$11.1M +1,243,934 New
SBH
37
Segall Bryant & Hamill
Illinois
$10.9M -$988K -110,237 -8%
EP
38
Eversept Partners
New York
$10.8M -$8.64M -964,798 -44%
Legal & General Group
39
Legal & General Group
United Kingdom
$10.8M +$2M +223,265 +23%
AQR Capital Management
40
AQR Capital Management
Connecticut
$10.3M -$472K -52,655 -4%
MGP
41
M&G plc
United Kingdom
$9.41M +$9.41M +1,046,016 New
Pictet Asset Management
42
Pictet Asset Management
Switzerland
$9.06M +$3.33M +356,717 +58%
PHP
43
Parkman Healthcare Partners
Connecticut
$9.03M +$66.6K +7,430 +0.7%
AG
44
Algert Global
California
$8.99M +$383K +42,753 +4%
Invesco
45
Invesco
Georgia
$8.9M +$224K +24,962 +3%
Barclays
46
Barclays
United Kingdom
$7.21M +$3.6M +401,512 +100%
TCM
47
Tang Capital Management
California
$7.17M – – –
DCM
48
Driehaus Capital Management
Illinois
$6.87M +$6.87M +766,899 New
SSA
49
Schonfeld Strategic Advisors
New York
$6.75M +$1.26M +140,765 +23%
First Trust Advisors
50
First Trust Advisors
Illinois
$6.52M +$2.17M +241,988 +50%
1
2
3 4 5